AS

Amarjit Singh Bhatia

Active Director Director DIN 00164862
DIN 00164862 First appointment Nov 1996 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 1996
Shareholding value β€’β€’β€’β€’ Premium profile

About Amarjit Singh Bhatia

Data last updated:

Amarjit Singh Bhatia is a Director at Aster Drugs And Pharmaceuticals Limited (since 1996). The company operates in Pharma.

DIN 00164862
Primary Designation Director
Industry Pharma
First Appointment 29 Nov 1996
Oldest Company Age 32 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Nov 19961994Active

Directorship timeline

Open interactive timeline →
Aster Drugs And Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Amarjit Singh Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amarjit Singh Bhatia

Amarjit Singh Bhatia currently holds 1 directorship: Aster Drugs And Pharmaceuticals Limited (Director, since 29 Nov 1996).

Amarjit Singh Bhatia was first appointed on 29 Nov 1996 as Director at Aster Drugs And Pharmaceuticals Limited.

The current boards of Amarjit Singh Bhatia's companies include Davinder Singh Dhaliwal (Aster Drugs And Pharmaceuticals Limited), Inderjit Singh Chopra (Aster Drugs And Pharmaceuticals Limited), Neena Syan (Aster Drugs And Pharmaceuticals Limited), Umesh Ambikaprasad Mishra (Aster Drugs And Pharmaceuticals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available